CASP Mission Award winner Allyson Moore on why meaningful ABA outcomes resist a single score, the Vineland’s limits, value-based care, and adult autism care.
Key Takeaways
- The field still struggles to agree on what a meaningful ABA outcome is, and value-based care is raising the stakes. Moore argues outcomes are irreducibly individual, so a benchmark that fits a seven-year-old will not likely fit a 37-year-old.
- Her answer is to standardize the process rather than the number: how clinicians choose goals and procedures, measure social validity and satisfaction, and document operational quality. She borrows procedural-safeguard thinking from medicine instead of fixing on any single tool.
- A standardized score can miss what matters: Moore recalls a client whose communication score could not move even as his aggression fell from roughly every two hours to six months without an incident. The 2026 CASP and APBA ASD Assessment Guidelines she co-chaired push a multimodal approach for exactly this reason.
- The path forward runs through scalable training and the autistic adults the system underfunds, with free resources and a competency roadmap so clinicians without elite mentorship can still deliver quality. California’s regional-center overhaul is her live test case for whether standardization protects access or hardens into a ceiling.
When Allyson Moore talks about the CASP Mission Award she received this year, she does not dwell on the trophy. She dwells on the word. “There’s one word that I align with the most, and it’s the mission award,” she told Acuity Media Network, “because to me it’s about that kind of servant leadership and helping fulfill the mission that we’re all having in terms of access to care.” She joked that if any single recognition had to carry her name, this was the right one.
Moore is the Chief Professional Standards Officer at the Center for Applied Behavior Analysis (CABA) in Los Angeles, a behavior analyst, licensed marriage and family therapist, and past president of the Association of Professional Behavior Analysts (APBA). She has given close to two decades to the field’s volunteer infrastructure, six years on the CalABA board and 14 non-consecutive years with APBA, and she now chairs CASP’s Client Outcomes special interest group. Speaking in her personal capacity, she described a career organized around a primary idea: that in autism services, quality cannot be read off one number, because the outcomes that matter are never the same twice. That idea runs from the clients she has treated to the guidelines she now helps write.
Moore entered the field in 1996, when more than half of her early years of practice, by her count, predated any health insurance mandate for ABA. Services were funded by schools and regional centers, and no one billed in 15-minute units. She was mentored by clinicians she now calls irreplaceable, among them Dr. Jane Howard, Dr. Gina Green, and Dr. Bridget Taylor of the Alpine Learning Group. That apprenticeship shaped both her standards and her worry: the field cannot clone the mentors who made her, so it has to build systems that carry their judgment to everyone else.
Client Outcomes, the ASD Assessment Guidelines, and the CASP Mission Award
Moore’s service record is the reason her name reached the CASP stage. The Mission Awards, presented at the Council of Autism Service Providers’ annual conference and overseen by CASP Chief Executive Lorri Unumb, recognize people who have materially advanced the organization’s mission. The same conference honored Dr. Missy Olive with its Non-Member award. Moore has chaired the Client Outcomes special interest group for several years, a role that has moved to the center of the field’s attention as payers and providers argue over what a good outcome even is. She also helps lead CASP’s California advocacy work, and last spring she co-chaired the subject-matter experts behind the 2026 ASD Assessment Guidelines, a joint project of CASP and APBA supported by a grant from the Behavior Analyst Certification Board.
Her path into that work began with a nudge. When APBA formed in the late 2000s, its founders wanted master’s-level practitioners and West Coast representation on the board, and Green put Moore’s name forward. She served, cycled off, and returned years later as California’s nominee. “Bridget Taylor can’t have 80,000 mentees,” she said, naming the problem that has animated her ever since: the best training in ABA has never been scalable, and quality erodes wherever it fails to reach. Free, expert-built resources, she argues, are one of the few honest answers to that.
Why a Meaningful ABA Outcome Resists a Single Score
Ask Moore what consensus on outcomes should look like, and she moves the target off the outcome itself. “I would like to see us focusing more on the structure and process of standardization,” she said, “and less around pinpointing a specific tool or goal.” The reason is that autism does not behave like the conditions medicine measures cleanly. With diabetes, she noted, everyone agrees the indicator is the A1C level. “It’s not the same with autism.” A meaningful outcome for a seven-year-old and one for a 37-year-old are not the same target, so a field that defines quality by a shared endpoint will keep failing the people who do not fit it.
What can be standardized, in her view, is how clinicians get there: how they involve the client and family in choosing goals, how they select procedures, and how they measure whether the person is actually better. This perspective is reflected in a risk-driven framework she co-authored, which emphasizes systematically identifying and minimizing risks to achieving the client’s desired outcomes by evaluating the social validity of goals, the appropriateness of procedures, and the meaningfulness of outcomes throughout service delivery. That means looking past a score on a tool to social validity and to client and caregiver satisfaction, and to operational markers of quality, such as whether an organization delivers its required supervision and moves staff to credentialed status on time. She points to medicine’s procedural safeguards as a model, the kind of simple, enforced checks that catch an error before it reaches a patient. The frame, she insists, is bigger than the child alone. “It’s not just the functioning of the child,” she said, “but the functioning of the child within the family unit and the family well-being.”
That process orientation collides with how insurance pays. Under managed care, behavior-analytic work is billed in 15-minute units and, outside assessment, is generally reimbursable only when it is face to face, even though a great deal of necessary clinical work is neither. “Just because something isn’t billable doesn’t mean it’s not part of the service,” she said. The harder problem is medical necessity itself. A physical therapist can honor a patient’s wish to dance at a daughter’s wedding while billing for the strengthening that makes it possible; behavior analysts, she argued, have to draw the same line between what is medically necessary and what is merely beneficial, without losing sight of what the client actually wants. It is the same medical-necessity question now driving federal program integrity audits, and as value-based care enters the picture, the distinction only grows more consequential.
The assessment guidelines are an attempt to arm clinicians for exactly these conversations. Their core, she said, is that assessment in ABA should be multimodal, drawing on interviews, record review, and direct observation rather than a single prescribed measure, and that assessment never really stops. “We’re always assessing. That’s our science,” she said, describing the work as a decision tree the clinician has to justify rather than a fixed sequence. She worries the document has been misjudged by people who never read it. “There’s been people who may have made assumptions of what it is and what it’s not without doing a proper review of it,” she said.
Nowhere are the stakes clearer than in the tool payers reach for by default. When the field lacks consensus, Moore said, “the payers are going to fill that void” and name a standard themselves, often the Vineland. She recalled a client whose communication score sat at 40 and, because he had apraxia and little vocal-verbal behavior, was never going to move, no matter how much he progressed. Required to administer the Vineland, she did, then documented what the instrument could not: aggression that had fallen from roughly every two hours to six months without a single incident report. “That’s not going to be captured on a standardized assessment tool,” she said. A clinician who does not understand the Vineland’s limits, she argued, cannot explain that gap to a payer, and the client pays for it. Behavior analysts carry two ethical obligations at once, she added: to honor the payer contract they entered, because access to care depends on it, and to advocate for appropriate services anyway. Nothing stops a clinician from administering a more sensitive measure alongside the required one, except the question of who will pay for the time.
Adult Autism Services, California Regional Centers, and a Roadmap for Clinicians
For all that the field argues about children, Moore keeps returning to the people it forgets. “The adult population is the least funded population on the spectrum,” she said, “and I would argue many have the highest level of needs.” Fewer providers serve adults, and a persistent misconception holds that intervention only matters in childhood. “There is nothing that says that you have an expiration date of benefiting from ABA,” she said. She is especially interested in adults who received ABA as children, aged out, and could benefit again, and in outcomes framed around sustainability and self-efficacy rather than a closing test score.
California is where those questions get concrete. The state runs a system Moore calls genuinely unique: 21 regional centers, funded through the Department of Developmental Services under the Lanterman Act, that coordinate services for people with developmental disabilities from birth through the end of life. That system is now moving through a sweeping overhaul. What began as rate reform, standardized rate models the state is required to update and post every two years starting in January 2026, has, in Moore’s telling, “started off as rate reform, and then it became service reform,” as the discretion regional centers long held over how services were authorized gives way to common standards. She sees both promise and hazard in that: standardization can protect access, or, if providers stop advocating, it can harden into a ceiling. Layered on top is the rule that regional centers are the payer of last resort, meaning families must exhaust private insurance and Medi-Cal, often with written denials in hand, before regional center dollars flow, a threshold that can itself become a barrier. And the two systems answer to different tests, since regional center services turn on the Lanterman Act’s aims of autonomy and community integration rather than the narrower question of medical necessity.
Which brings Moore back to where she started, and to the mentors she cannot replicate. The way to protect quality at scale, she argues, is to build the infrastructure the field still lacks: not just minimum hours and a passing exam score, but a roadmap of competencies that tells a new clinician what good practice actually requires, by population, setting, and age. The assessment guidelines, free to read, are one piece of that. So, in her framing, is the award itself, less a career capstone than a description of the job that remains: cultivating standards, sharing them, and advocating for the access that lets them matter. In a field still arguing over which number counts, Moore’s wager is that the number was never the point. The process was.
